+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP)



Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP)



Journal of Neurology 266(2): 468-475



HRUS is increasingly being used in the diagnosis and evaluation of autoimmune neuropathies such as CIDP. Recently, studies focused not only on changes of nerves size, but also the fascicular structure and the echogenicity changes in CIDP. However, little is known about the alterations of echogenicity in the long-term course in CIDP. The aim of this study was to evaluate echogenicity in CIDP patients in a long-term follow-up period and to analyze the benefit of the evaluation of echogenicity compared to nerve size. 20 patients fulfilling the definite diagnostic criteria of CIDP received clinical examination, nerve conduction studies and HRUS every 6 months over a median follow-up time of 34 months. Patients were divided into clinically stable/regressive disease course or progressive disease course according to the development of the inflammatory neuropathy cause and treatment overall disability sum score. Echogenicity of peripheral nerves was measured semi-automated and quantitative. Echogenicity was divided into three classes by fraction of black: hypoechogenic, mixed hypo-/hyperechogenic, hyperechogenic. Patients with hyperechogenic arm nerves more frequently show clinical worsening, whereas patients with hypoechogenic arm nerves remain stable or even improved over time. In the long-term course of the disease, echogenicity mostly did not change, and if changes occured echogenicity did not correspond to ODSS changes. Echogenicity of the arm nerves in CIDP may be used as a prognostic marker, but not as a follow-up tool for evaluating clinical changes. Further studies in a larger cohort are needed to confirm these results.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066010927

Download citation: RISBibTeXText

PMID: 30554264

DOI: 10.1007/s00415-018-9158-3


Related references

High-resolution nerve ultrasound and magnetic resonance neurography as complementary neuroimaging tools for chronic inflammatory demyelinating polyneuropathy. Therapeutic Advances in Neurological Disorders 11: 1756286418759974, 2018

Nerve conduction abnormalities in chronic inflammatory demyelinating polyneuropathy (CIDP). Rinsho Shinkeigaku 31(12): 1333-1336, 1991

Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy. Journal of Clinical Neuroscience 57: 198-201, 2018

Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)--diagnosis confirmed by nerve biopsy. Neurophysiologie Clinique 34(2): 71-79, 2004

Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy. Clinical Neurophysiology 125(3): 635-641, 2014

Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy. Journal of Neuroimaging 25(6): 931-939, 2016

Peripheral nerve block ultrasound guided in a patient with chronic inflammatory demyelinating polyneuropathy. Revista Espanola de Anestesiologia Y Reanimacion 61(2): 113-114, 2014

Correlation of nerve ultrasound, electrophysiological and clinical findings in chronic inflammatory demyelinating polyneuropathy. Journal of Neuroimaging 25(2): 207-216, 2016

Nerve ultrasound score in distinguishing chronic inflammatory demyelinating polyneuropathy from GuillainBarr syndrome. Journal of the Neurological Sciences 333: E442-E443, 2013

Nerve Ultrasound, Electrophysiological, and Clinical Changes in Treatment-Naive Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report. Journal of Clinical Neurophysiology 36(1): 82-84, 2019

Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcota Mariea Tooth disease distinction from patients with chronic inflammatory demyelinating polyneuropathy. 2013

Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. Journal of Neurology 260(10): 2580-2587, 2013

A case of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with bilateral recurrent nerve palsy and primary alveolar hypoventilation--comparative studies of the histological findings of the two sural nerve biopsies with 9 years interval. Rinsho Shinkeigaku 34(7): 712-716, 1994

High dose intravenous immunoglobulin ivig in the treatment of chronic inflammatory demyelinating polyneuropathy cidp. Annals of Allergy 64(1): 81, 1990

High titer serum anti tubulin antibodies are a marker for chronic inflammatory demyelinating polyneuropathy cidp. Neurology 42(4 Suppl. 3): 409, 1992